Ethambutol is a drug used, alone or in combination with other drugs, to treat tuberculosis and other infections. It is sold under the trade names Myambutol (X-GEN Pharmaceuticals) and Servambutol (Sandoz). Although it is effective, it has several adverse side effects, such as vision, liver, and allergy problems.
L. L. Kiessling (University of Wisconsin–Madison), in her Fred Kavli Innovations in Chemistry Lecture at the spring 2015 ACS National Meeting in Denver, described ethambutol as “a not great drug”. She advocated targeting microbial cell-surface carbohydrates to combat mycobacterial diseases. In particular, she suggested galactofuranoses as particularly attractive targets for protein antibiotics.
Learn more about this molecule from CAS, the most authoritative and comprehensive source for chemical information.
Molecule of the Week needs your suggestions!
If your favorite molecule is not in our archive, please send us a message. The molecule can be notable for its current or historical importance or for any quirky reason. Thank you!
Stay Ahead of the Chemistry Curve
Learn how ACS can help you stay ahead in the world of chemistry.